Xencor (XNCR) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Powered by 
Analysis
Xencor (XNCR) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 88.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.93% |
| Mar 31, 2026 | 87.59% |
| Jun 30, 2018 | -61.31% |
| Mar 31, 2018 | -67.88% |
| Dec 31, 2017 | 52.95% |
| Sep 30, 2017 | -35.73% |
| Jun 30, 2017 | -18.98% |
| Mar 31, 2017 | -42.52% |
| Dec 31, 2016 | 29.07% |
| Sep 30, 2016 | -65.23% |
| Jun 30, 2016 | 1,286.66% |
| Mar 31, 2016 | -246.54% |